Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on June 19, 2006.

The FlexShares High Yield Value-Scored Bond ETF (HYGV) made its debut on 07/17/2018, and is a smart beta exchange traded fund that provides broad exposure to the High-Yield/Junk Bond ETFs category of the market.

Designed to provide broad exposure to the Large Cap Value segment of the US equity market, the WisdomTree U.S. LargeCap Dividend ETF (DLN) is a passively managed exchange traded fund launched on June 16, 2006.

Looking for broad exposure to the Technology - Broad segment of the equity market? You should consider the Fidelity MSCI Information Technology Index ETF (FTEC), a passively managed exchange traded fund launched on October 21, 2013.

A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market.

Launched on August 13, 2013, the Schwab Fundamental U.S. Large Company ETF (FNDX) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Value segment of the US equity market.

If you're interested in broad exposure to the Technology - Software segment of the equity market, look no further than the Invesco AI and Next Gen Software ETF (IGPT), a passively managed exchange traded fund launched on June 23, 2005.

Making its debut on 02/23/2016, smart beta exchange traded fund Janus Henderson Small Cap Growth Alpha ETF (JSML) provides investors broad exposure to the Style Box - Small Cap Growth category of the market.

A smart beta exchange traded fund, the WisdomTree U.S. SmallCap Dividend ETF (DES) debuted on 06/16/2006, and offers broad exposure to the Style Box - Small Cap Value category of the market.

Launched on July 24, 2000, the iShares S&P Mid-Cap 400 Growth ETF (IJK) is a passively managed exchange traded fund designed to provide a broad exposure to the Mid Cap Growth segment of the US equity market.

Designed to provide broad exposure to the Style Box - Large Cap Growth category of the market, the Invesco Large Cap Growth ETF (PWB) is a smart beta exchange traded fund launched on 03/03/2005.

The Vanguard Financials ETF (VFH) was launched on January 26, 2004, and is a passively managed exchange traded fund designed to offer broad exposure to the Financials - Broad segment of the equity market.

Looking for broad exposure to the Large Cap Value segment of the US equity market? You should consider the Vanguard Russell 1000 Value ETF (VONV), a passively managed exchange traded fund launched on September 22, 2010.

Looking for broad exposure to the Financials - Broad segment of the equity market? You should consider the iShares U.S. Financials ETF (IYF), a passively managed exchange traded fund launched on May 22, 2000.

I reiterate my buy rating on Merck, citing its attractive valuation and improving technicals despite sector headwinds. Merck's recent earnings beat was driven by strong oncology and cardiovascular portfolios, offsetting Gardasil weakness and Keytruda patent concerns. The stock offers a solid 4% dividend yield, low PEG ratio, and consistent growth, making it appealing for income and value investors.

Phreesia is on track to meet FY26 revenue targets, driven by steady client growth and strong average revenue per client. Margins are improving, with adjusted EBITDA trending toward high teens and free cash flow beginning to emerge, supporting long-term leverage. Valuation is balanced at 3.3x forward EV/S, but real upside depends on sustained margin expansion and cash flow conversion.

Lately it seems as if most roads lead to the democratization of private markets.

Although Apple (NASDAQ: AAPL) remains one of the most reliable long-term stocks, history suggests that September should be approached with caution.

IMTX, ERJ and BFIN have been added to the Zacks Rank #5 (Strong Sell) List on August 15, 2025.

- Q2 revenue of $155.6 million up 56.8% year-over-year and 121.9% sequentially- $69.5 million revenue from external sale of SEALMINER A2s- On track to achieve 40 EH/s of self-mining by end of October and exceed 40 EH/s by year-end- Entered into advanced negotiations with a development partner regarding Clarington, Ohio site for HPC/AI.